You'll want to base your prescribing decisions on reliable information, which means that it should not be influenced by vested interests. Information on new medicines usually comes from pharmaceutical companies, who understandably want to focus attention on the benefits of their products and not compare them critically with alternative treatments.
One of the ways in which Veterinary Prescriber can help is to take an impartial look at the evidence. An example of how we do this is in an article entitled "Post-operative pain in cats: robenacoxib or meloxicam?" (first published by Veterinary Prescriber in May 2013), the starting point for which was an advert for robenacoxib claiming superior pain relief.
Was the evidence sufficiently compelling to want to choose robenacoxib over meloxicam? See for yourself. We're planning future articles on new drugs or new claims (e.g. there's one in preparation on oclacitinib for itchy dogs) Visit the website and leave your contact details. You can also leave suggestions for article topics.